if you think about the pacemakers I would not count on Medtronic at this point but more on Guidant. First deals -based on the patents of AMRIS- could be MRI safe surgical instruments and the vena cava filter.
What could be interesting is the AMRIS fully visible stent...if it turn out at the best that could be an update for the Liberti stent. We´ll see how things turn out the weeks ahead.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.